Eli Lilly reported strong earnings and raised guidance. Read more on what could be next for this biotech giant.

Eli Lilly remains a top GARP opportunity, with Q3 results reinforcing its robust business growth and dominance in incretin ...

Eli Lilly shares rise as Q3 revenue jumps 54% to $17.6 billion, earnings top estimates, and analysts lift price targets on ...

Eli Lilly LLY reported 54% revenue growth in the third quarter as its diabetes and obesity drug tirzepatide ...

Wall Street eyed a US-China truce agreed by Trump and Xi, cooling hopes for a December rate cut and the next batch of Big Tech earnings.

Founded in 2022 by Population Health Partners and ARCH Venture Partners, the biotech venture giant led by Bob Nelsen, Metsera ...

Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Euro US Dollar, US Dollar Japanese Yen, Nasdaq 100, Gold Spot US Dollar. Read 's Market Analysis on Investing.com ...

U.S. stock futures pointed higher on Friday, suggesting Wall Street may bounce back after Thursday’s selloff, as investors ...

D ow Jones futures climbed slightly early Friday, while S&P 500 futures and Nasdaq futures rose solidly. Apple AAPL and ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the ...